News - BioPharm International

ADVERTISEMENT

News

Analyzing Nano Drugs

December 12, 2013

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Roche, Prothena Form mAb Pact

December 12, 2013

Roche and Prothena sign deal worth up to $600 million to develop and commercialize antibodies that target alpha-synuclein.

Alvotech Plans Multimillion Biosimilars Investment

December 6, 2013

Alvotech plans investment in biosimilars portfolio and manufacturing facility.

European Medicines Agency Revises Orphan Drugs Policy

December 3, 2013

EMA revises its polices on fee reductions for orphan drugs for 2014.

President Obama Signs Drug Quality and Security Act

December 2, 2013

Drug Quality and Security Act gives FDA authority over compounding pharmacies.

USP and Other Organizations Unite in Campaign to Raise Awareness of Counterfeit Medicines

November 29, 2013

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

Merck KGaA Invests in Research Partnerships in Israel

November 27, 2013

Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.

Lilly Funds Start Up of Biosciences Research Institute

November 27, 2013

The Indiana Biosciences Research Institute will accelerate collaboration and focus on human-health solutions.

Mylan Receives Approval for Biosimilar in India; Reaches Settlement with Teva on Copaxone

November 26, 2013

Mylan and the Indian biopharmaceutical company Biocon receive approval for a biosimilar version of trastuzumab in India. Also, Mylan and Teva reach settlement on Copaxone in the EU.

ADVERTISEMENT

ADVERTISEMENT

Click here